Current clinically focused biological aging research, or translational geroscience is going through incredible progress. There’s finally an emerging scientific consensus about our understanding of the major molecular and cellular hallmark processes driving biological aging. Yet, this consensus is not reflected in a consensus definition of what biological aging is. In the literature, for some reason, […]
Dear AgeCurve Users, We have disabled reporting oral microbiome features within the AgeCurve App due to the following reasons: We have always been focusing on reporting deep proteomic aging patterns using expression levels of human proteins and reporting oral microbiome information next to this core information has been confusing for many users. Basically we have […]
It’s so fitting to announce here that Aubrey de Grey has joined AgeCurve‘s Advisory Board. Aubrey is the number one individual inspirational source of serious and scientifically minded longevity enthusiasts over the world.
AgeCurve’s founder and director, Attila Csordas has been invited to give a talk at the upcoming Undoing Aging, 2018 conference, in Berlin, organised by the SENS Research Foundation and the Forever Healthy Foundation. The conference features heavyweights of molecular biogerontology worldwide, both from academy and the biomedical industry. Attila is scheduled to talk on the […]
We are finally in a position to run a pilot programme in the US. We are now offering a chance for some curious, early adopter Americans to understand what deep age and deep agings profiling mean according to AgeCurve’s view focusing on proteins via personal proteomics. Please email us over at if interested. Thank you.
In July I have announced that Kathryn Lilley is joining our Advisory Board, advising us on science related matters. Today I’m thrilled to announce that Daniel Reda is joining our Board as well, helping us to navigate our small boat with his California trained, biomedical business skills. Daniel and I were colleagues at Singularity University […]
I am thrilled to announce that Professor Kathryn Lilley, of Cambridge University, is joining AgeCurve’s Advisory Board. Kathryn is the director of Cambridge Centre for Proteomics with a deep understanding of mass spectrometry based proteomics. I was privileged to work with Kathryn before and since AgeCurve is a Cambridge-based startup it was rather predictable for […]